Noticias de ANIP_US

Noticias del mercado

Últimas noticias sobre ANIP_US — 250 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ANIP_US ✕ 250 resultados
06/03/2026 ANIP_US — Benzinga
Stephen P Carey At ANI Pharmaceuticals Decides to Exercises Options Worth $86K
04/03/2026 ANIP_US — Finviz
Generic Pharmaceuticals Q4 Earnings: ANI Pharmaceuticals (NASDAQ:ANIP) Simply the Best
04/03/2026 ANIP_US — Investing.com
Ani pharmaceuticals head of rare disease sells $30k in stock
03/03/2026 ANIP_US — Yahoo Finance
ANI Pharmaceuticals Targets $1B+ Sales in 2026, Pivots to Rare Disease Growth at Raymond James Conf.
03/03/2026 ANIP_US — Stock Titan
Director at ANI Pharmaceuticals (ANIP) sells 6,000 shares
03/03/2026 ANIP_US — TradingView
ANI Pharmaceuticals projects >$1B revenue in 2026, guides $275–$290M adjusted EBITDA
03/03/2026 ANIP_US — Benzinga
SVP Of ANI Pharmaceuticals Purchased $464K In Stock - ANI Pharmaceuticals (NASDAQ:ANIP)
02/03/2026 ANIP_US — Stock Titan
ANI Pharmaceuticals (ANIP) CEO logs restricted stock grant and tax-withholding share disposition
02/03/2026 ANIP_US — Seeking Alpha
ANI Pharmaceuticals Q4 2025: Strong Growth, But Execution Risks Emerge (NASDAQ:ANIP)
28/02/2026 ANIP_US — Stock Titan
ANI Pharmaceuticals (ANIP) SVP logs stock grant and tax withholding in Form 4
27/02/2026 ANIP_US — Investing.com Canada
ANI Pharmaceuticals Inc (ANIP) Q4 2025 Earnings Call Highlights: Record Revenue and Strong ... By GuruFocus
27/02/2026 ANIP_US — Quiver Quantitative
ANI Pharmaceuticals Reports Record Quarterly and Full Year Revenue Growth, Driven by Rare Disease Portfolio
27/02/2026 ANIP_US — Stock Titan
Rare disease drug Cortrophin Gel drives 43.8% sales jump at ANI
27/02/2026 ANIP_US — Investing.com
ANI Pharma Q4 2025 slides: rare disease shift drives 44% revenue growth
27/02/2026 ANIP_US — MarketScreener
(ANIP) ANI Pharmaceuticals Expects 2026 Revenue Range $1.06B - $1.12B, vs. FactSet Est of $1.01B
27/02/2026 ANIP_US — Yahoo Finance
ANI Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary
27/02/2026 ANIP_US — GlobeNewswire
ANI Pharmaceuticals Reports Record Fourth Quarter and Full
27/02/2026 ANIP_US — Yahoo Finance
ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Financial Guidance
27/02/2026 ANIP_US — TradingView
ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2025 Financial Results
27/02/2026 ANIP_US — GlobeNewswire
ANI Pharmaceuticals Reports Record Fourth Quarter and Full

Página 12 de 13

keyboard_arrow_up